Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 385

1.

A double amino-acid change in the HLA-A peptide-binding groove is associated with response to psychotropic treatment in patients with schizophrenia.

Le Clerc S, Taing L, Fond G, Meary A, Llorca PM, Blanc O, Beaune P, Rajagopal K, Jamain S, Tamouza R, Zagury JF, Leboyer M.

Transl Psychiatry. 2015 Jul 28;5:e608. doi: 10.1038/tp.2015.97.

PMID:
26218850
2.

Resolution of a manic episode treated with activated charcoal: Evidence for a brain-gut axis in bipolar disorder.

Hamdani N, Boukouaci W, Hallouche MR, Charron D, Krishnamoorthy R, Leboyer M, Tamouza R.

Aust N Z J Psychiatry. 2015 Jul 24. pii: 0004867415595873. [Epub ahead of print] No abstract available.

PMID:
26209321
3.

Is it time for immuno-psychiatry in bipolar disorder and suicidal behaviour?

Leboyer M.

Acta Psychiatr Scand. 2015 Jul 20. doi: 10.1111/acps.12456. [Epub ahead of print] No abstract available.

PMID:
26189642
4.

Corpus callosum area in patients with bipolar disorder with and without psychotic features: an international multicentre study.

Sarrazin S, d'Albis MA, McDonald C, Linke J, Wessa M, Phillips M, Delavest M, Emsell L, Versace A, Almeida J, Mangin JF, Poupon C, Le Dudal K, Daban C, Hamdani N, Leboyer M, Houenou J.

J Psychiatry Neurosci. 2015 Jul 7;40(4):140262. doi: 10.1503/jpn.140262. [Epub ahead of print]

5.

A National network of schizophrenia expert centres: An innovative tool to bridge the research-practice gap.

Schürhoff F, Fond G, Berna F, Bulzacka E, Vilain J, Capdevielle D, Misdrahi D, Leboyer M, Llorca PM; FondaMental Academic Centers of Expertise for Schizophrenia (FACE-SZ) collaborators.

Eur Psychiatry. 2015 Jun 10. pii: S0924-9338(15)00111-X. doi: 10.1016/j.eurpsy.2015.05.004. [Epub ahead of print]

PMID:
26072427
6.

Adherence to medication is associated with non-planning impulsivity in euthymic bipolar disorder patients.

Belzeaux R, Boyer L, Mazzola-Pomietto P, Michel P, Correard N, Aubin V, Bellivier F, Bougerol T, Olie E, Courtet P, Etain B, Gard S, Kahn JP, Passerieux C, Leboyer M, Henry C, Azorin JM; French Advanced Centers of Expertise for Bipolar Disorders (FACE-BD) Collaborators.

J Affect Disord. 2015 Sep 15;184:60-6. doi: 10.1016/j.jad.2015.05.041. Epub 2015 May 30.

PMID:
26070047
7.

Mood disorders are associated with a more severe hypovitaminosis D than schizophrenia.

Belzeaux R, Boyer L, Ibrahim EC, Féron F, Leboyer M, Fond G.

Psychiatry Res. 2015 May 19. pii: S0165-1781(15)00261-9. doi: 10.1016/j.psychres.2015.04.039. [Epub ahead of print]

PMID:
26027439
8.

Increased risk of suicide attempt in bipolar patients with severe tobacco dependence.

Ducasse D, Jaussent I, Guillaume S, Azorin JM, Bellivier F, Belzeaux R, Bougerol T, Etain B, Gard S, Henry C, Kahn JP, Leboyer M, Loftus J, Passerieux C, Courtet PH, Olié E; FondaMental Advanced Centers of Expertise in Bipolar Disorders (FACE-BD) Collaborators.

J Affect Disord. 2015 Sep 1;183:113-8. doi: 10.1016/j.jad.2015.04.038. Epub 2015 May 13.

PMID:
26001671
9.

Bipolar patients referred to specialized services of care: Not resistant but impaired by sub-syndromal symptoms. Results from the FACE-BD cohort.

Henry C, Etain B, Godin O, Dargel AA, Azorin JM, Gard S, Bellivier F, Bougerol T, Kahn JP, Passerieux C, Aubin V, Courtet P, Leboyer M; FACE-BD group.

Aust N Z J Psychiatry. 2015 May 19. pii: 0004867415585582. [Epub ahead of print]

PMID:
25991763
10.

Genetic association study of circadian genes with seasonal pattern in bipolar disorders.

Geoffroy PA, Lajnef M, Bellivier F, Jamain S, Gard S, Kahn JP, Henry C, Leboyer M, Etain B.

Sci Rep. 2015 May 19;5:10232. doi: 10.1038/srep10232.

11.

Violent suicidal behaviour in bipolar disorder is associated with nitric oxide synthase 3 gene polymorphism.

Oliveira J, Debnath M, Etain B, Bennabi M, Hamdani N, Lajnef M, Bengoufa D, Fortier C, Boukouaci W, Bellivier F, Kahn JP, Henry C, Charron D, Krishnamoorthy R, Leboyer M, Tamouza R.

Acta Psychiatr Scand. 2015 May 4. doi: 10.1111/acps.12433. [Epub ahead of print]

PMID:
25939888
12.

Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis.

Sutterland AL, Fond G, Kuin A, Koeter MW, Lutter R, van Gool T, Yolken R, Szoke A, Leboyer M, de Haan L.

Acta Psychiatr Scand. 2015 Apr 15. doi: 10.1111/acps.12423. [Epub ahead of print]

PMID:
25877655
13.

Cognitive deterioration among bipolar disorder patients infected by Toxoplasma gondii is correlated to interleukin 6 levels.

Hamdani N, Daban-Huard C, Lajnef M, Gadel R, Le Corvoisier P, Delavest M, Carde S, Lépine JP, Jamain S, Houenou J, Galeh B, Richard JR, Aoki M, Charron D, Krishnamoorthy R, Yolken R, Dickerson F, Tamouza R, Leboyer M.

J Affect Disord. 2015 Jul 1;179:161-6. doi: 10.1016/j.jad.2015.03.038. Epub 2015 Apr 1.

PMID:
25863913
14.

Complex nature of apparently balanced chromosomal rearrangements in patients with autism spectrum disorder.

Tabet AC, Verloes A, Pilorge M, Delaby E, Delorme R, Nygren G, Devillard F, Gérard M, Passemard S, Héron D, Siffroi JP, Jacquette A, Delahaye A, Perrin L, Dupont C, Aboura A, Bitoun P, Coleman M, Leboyer M, Gillberg C, Benzacken B, Betancur C.

Mol Autism. 2015 Mar 25;6:19. doi: 10.1186/s13229-015-0015-2. eCollection 2015.

15.

Combined effect of TLR2 gene polymorphism and early life stress on the age at onset of bipolar disorders.

Oliveira J, Etain B, Lajnef M, Hamdani N, Bennabi M, Bengoufa D, Sundaresh A, Chaabane AB, Bellivier F, Henry C, Kahn JP, Charron D, Krishnamoorthy R, Leboyer M, Tamouza R.

PLoS One. 2015 Mar 19;10(3):e0119702. doi: 10.1371/journal.pone.0119702. eCollection 2015.

16.

The optimization of treatment and management of schizophrenia in Europe (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics.

Leucht S, Winter-van Rossum I, Heres S, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leweke FM, Lewis S, McGuire P, Meyer-Lindenberg A, Rujescu D, Kapur S, Kahn RS, Sommer IE.

Schizophr Bull. 2015 May;41(3):549-58. doi: 10.1093/schbul/sbv019. Epub 2015 Mar 18.

PMID:
25786408
17.

Treatment with anti-toxoplasmic activity (TATA) for toxoplasma positive patients with bipolar disorders or schizophrenia: a cross-sectional study.

Fond G, Boyer L, Gaman A, Laouamri H, Attiba D, Richard JR, Delavest M, Houenou J, Le Corvoisier P, Charron D, Krishnamoorthy R, Oliveira J, Tamouza R, Yolken R, Dickerson F, Leboyer M, Hamdani N.

J Psychiatr Res. 2015 Apr;63:58-64. doi: 10.1016/j.jpsychires.2015.02.011. Epub 2015 Feb 24.

PMID:
25769398
18.

The promise of biological markers for treatment response in first-episode psychosis: a systematic review.

Fond G, d'Albis MA, Jamain S, Tamouza R, Arango C, Fleischhacker WW, Glenthøj B, Leweke M, Lewis S, McGuire P, Meyer-Lindenberg A, Sommer IE, Winter-van Rossum I, Kapur S, Kahn RS, Rujescu D, Leboyer M.

Schizophr Bull. 2015 May;41(3):559-73. doi: 10.1093/schbul/sbv002. Epub 2015 Mar 10.

PMID:
25759473
19.

Modeling determinants of medication attitudes and poor adherence in early nonaffective psychosis: implications for intervention.

Drake RJ, Nordentoft M, Haddock G, Arango C, Fleischhacker WW, Glenthøj B, Leboyer M, Leucht S, Leweke M, McGuire P, Meyer-Lindenberg A, Rujescu D, Sommer IE, Kahn RS, Lewis SW.

Schizophr Bull. 2015 May;41(3):584-96. doi: 10.1093/schbul/sbv015. Epub 2015 Mar 5.

PMID:
25750247
20.

C-reactive protein alterations in bipolar disorder: a meta-analysis.

Dargél AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M.

J Clin Psychiatry. 2015 Feb;76(2):142-50. doi: 10.4088/JCP.14r09007.

PMID:
25742201
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk